TYSABRI
TYSABRI
Approved
DIN Number
02286386
Drug Class
Human
Market Date
Nov 21, 2006
Company
HC
Biogen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02286386
AIG Number0151674001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AG03 NATALIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NATALIZUMABActive
Strength: 300 MG / 15 ML
Monograph: NATALIZUMAB